Table of contents
Scleredema
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of scleredema are prepared by our editorial team based on guidelines from the European Academy of Dermatology and Venereology (EADV 2017).
1
Screening and diagnosis
Medical management
Indications for treatment
As per EADV 2017 guidelines:
Do not initiate treatment in patients with type 1 scleredema, as it is self-limited and usually resolves in a short period of time.
D
Initiate treatment for an underlying condition in patients with types 2 and 3 scleredema.
E
More topics in this section
Treatment options
Glycemic control